Vimarsana
Biggest News Aggregation in the World

Page 13 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gamida Cell Today - Breaking & Trending Today

Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference - Vimarsana News

Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference

Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Michele Korfin, Chief Operating and Chief Commercial Officer, will present corporate... | June 7, 2023

JMP Securities Lowers Gamida Cell (NASDAQ:GMDA) Price Target to $6.00 - Vimarsana News

JMP Securities Lowers Gamida Cell (NASDAQ:GMDA) Price Target to $6.00

Gamida Cell (NASDAQ:GMDA – Get Rating) had its price objective trimmed by JMP Securities from $8.00 to $6.00 in a report published on Friday, The Fly reports. Other equities research analysts have also recently issued research reports about the stock. Needham & Company LLC cut their price objective on shares of Gamida Cell from $8.00 […]

How dating and relationship app Bumble added 98,000 paying users this quarter - Vimarsana News

How dating and relationship app Bumble added 98,000 paying users this quarter

Anu Subramanian discusses what's driving growth and shares her career journey.

Gamida Cell Appoints Terry Coelho as CFO - Vimarsana News

Gamida Cell Appoints Terry Coelho as CFO

Industry veteran Coelho brings more than 35 years of experience at emerging growth and global companies to role; Shai Lankry to leave company June 2 ... | May 22, 2023

Gamida Cell (NASDAQ:GMDA) Price Target Cut to $6.00 by Analysts at JMP Securities - Vimarsana News

Gamida Cell (NASDAQ:GMDA) Price Target Cut to $6.00 by Analysts at JMP Securities

Gamida Cell (NASDAQ:GMDA – Get Rating) had its price objective cut by JMP Securities from $8.00 to $6.00 in a research note released on Friday, The Fly reports. Other analysts have also issued research reports about the stock. HC Wainwright upped their target price on shares of Gamida Cell from $5.00 to $11.00 and gave […]

Source: wkrb13.com